ClinConnect ClinConnect Logo
Search / Trial NCT04687865

Constitution of a Biobank for Studies Related to Organ Transplantation (Lyon Centaure Biocollection)

Launched by HOSPICES CIVILS DE LYON · Dec 28, 2020

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called the Lyon Centaure Biocollection, is focused on collecting biological samples from patients who have received organ transplants. The main goal of the study is to better understand why some transplanted organs fail and to develop new tests, called biomarkers, that can help identify problems like organ rejection and other related health issues. By gathering these samples, researchers hope to improve care for transplant patients in the future.

To participate in this trial, you need to be at least 18 years old and have received an organ transplant. You'll also need to provide written consent to be part of the study. Unfortunately, if you are pregnant, breastfeeding, or do not have access to a social security system, you would not be eligible. If you join the study, you can expect to provide some biological samples, which will help researchers in their important work to enhance the outcomes for organ transplant recipients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or Female patient ≥18 years old
  • Recipient of an organ transplant
  • Written informed consent
  • Exclusion Criteria:
  • Non-affiliation to a social security system.
  • Subjects deprived of liberties
  • Pregnant or breastfeeding woman

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Lyon, , France

Lyon, Rhône, France

Patients applied

0 patients applied

Trial Officials

Olivier Thaunat, MD

Principal Investigator

Edouard Herriot Hospital - Transplantation department

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials